Holdings of iShares Biotechnology ETF
iShares Trust ·246 declared positions · as of Mar 31, 2026
Original filing · Net assets 8.1B $ · Ten largest lines: 47.4 % of the equity sleeve
Sector breakdown
- Health care 50.8 %
- Materials 1.7 %
- Industrials 1.1 %
- Unattributed 46.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 88.9 %
- NL 3.4 %
- DK 2.1 %
- BM 1.2 %
- CA 0.8 %
- DE 0.7 %
- IE 0.6 %
- FR 0.5 %
- CH 0.4 %
- KY 0.4 %
- SG 0.1 %
- JE 0.1 %
- Other countries 0.6 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 208 | 7.2B $ | 88.91 % |
| NL | 4 | 279.1M $ | 3.44 % |
| DK | 2 | 173.1M $ | 2.13 % |
| BM | 1 | 100.9M $ | 1.24 % |
| CA | 4 | 67.1M $ | 0.83 % |
| DE | 1 | 53.3M $ | 0.66 % |
| IE | 3 | 50.9M $ | 0.63 % |
| FR | 2 | 42M $ | 0.52 % |
| CH | 3 | 35.3M $ | 0.44 % |
| KY | 5 | 34.8M $ | 0.43 % |
| SG | 1 | 8.5M $ | 0.11 % |
| JE | 1 | 8.3M $ | 0.10 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Alumis Inc | 530,358 | 11.7M $ | 0.14 % |
| ZAI LAB LTD | 613,747 | 11.5M $ | 0.14 % |
| Nurix Therapeutics Inc | 720,848 | 11.2M $ | 0.14 % |
| Stoke Therapeutics Inc | 331,288 | 10.8M $ | 0.13 % |
| Intellia Therapeutics Inc | 835,337 | 10.7M $ | 0.13 % |
| AnaptysBio Inc | 192,136 | 10.7M $ | 0.13 % |
| Recursion Pharmaceuticals Inc | 3,419,857 | 10.5M $ | 0.13 % |
| Tyra Biosciences Inc | 272,474 | 10.4M $ | 0.13 % |
| Relay Therapeutics Inc | 980,266 | 9.8M $ | 0.12 % |
| Amylyx Pharmaceuticals Inc | 687,536 | 9.6M $ | 0.12 % |
| Novavax Inc | 1,157,114 | 9.4M $ | 0.12 % |
| Iovance Biotherapeutics Inc | 2,619,021 | 9.2M $ | 0.11 % |
| WaVe Life Sciences Ltd | 1,176,186 | 8.5M $ | 0.11 % |
| Immunocore Holdings PLC | 277,185 | 8.4M $ | 0.10 % |
| Novocure Ltd | 763,201 | 8.3M $ | 0.10 % |
| Galapagos NV | 271,893 | 8.2M $ | 0.10 % |
| Grifols SA | 976,161 | 7.8M $ | 0.10 % |
| Biohaven Ltd | 917,535 | 7.8M $ | 0.10 % |
| Nuvation Bio Inc | 1,795,888 | 7.7M $ | 0.09 % |
| AtaiBeckley Inc | 2,160,067 | 7.6M $ | 0.09 % |
| Taysha Gene Therapies Inc | 1,672,180 | 7.5M $ | 0.09 % |
| Sionna Therapeutics Inc | 185,101 | 7.4M $ | 0.09 % |
| Trevi Therapeutics Inc | 608,481 | 7.3M $ | 0.09 % |
| Mesoblast Ltd. | 460,143 | 7.1M $ | 0.09 % |
| Corvus Pharmaceuticals Inc | 473,326 | 6.9M $ | 0.09 % |
| Olema Pharmaceuticals Inc | 457,751 | 6.8M $ | 0.08 % |
| Rapport Therapeutics Inc | 217,759 | 6.8M $ | 0.08 % |
| uniQure NV | 413,699 | 6.8M $ | 0.08 % |
| Geron Corp | 4,513,103 | 6.7M $ | 0.08 % |
| Fortrea Holdings Inc | 693,057 | 6.5M $ | 0.08 % |
| Vir Biotechnology Inc | 704,449 | 6.3M $ | 0.08 % |
| Xencor Inc | 513,267 | 6.2M $ | 0.08 % |
| AbCellera Biologics Inc | 1,732,022 | 6M $ | 0.07 % |
| MBX Biosciences Inc | 199,599 | 6M $ | 0.07 % |
| Maze Therapeutics Inc | 197,936 | 5.9M $ | 0.07 % |
| CareDx Inc | 337,886 | 5.9M $ | 0.07 % |
| Theravance Biopharma Inc | 353,652 | 5.7M $ | 0.07 % |
| Monte Rosa Therapeutics Inc | 346,430 | 5.7M $ | 0.07 % |
| KalVista Pharmaceuticals Inc | 276,916 | 5.6M $ | 0.07 % |
| Janux Therapeutics Inc | 392,349 | 5.5M $ | 0.07 % |
| Pharvaris NV | 191,961 | 5.4M $ | 0.07 % |
| MannKind Corp | 2,199,381 | 5.4M $ | 0.07 % |
| ORIC Pharmaceuticals Inc | 424,422 | 5.4M $ | 0.07 % |
| Castle Biosciences Inc | 215,689 | 5.3M $ | 0.07 % |
| Annexon Inc | 952,884 | 5.3M $ | 0.07 % |
| UroGen Pharma Ltd | 286,041 | 5.1M $ | 0.06 % |
| Kura Oncology Inc | 628,449 | 5.1M $ | 0.06 % |
| Inhibrx Biosciences Inc | 75,835 | 5.1M $ | 0.06 % |
| Stevanato Group SpA | 370,391 | 5.1M $ | 0.06 % |
| Arbutus Biopharma Corp | 1,119,437 | 5M $ | 0.06 % |
| Septerna Inc | 200,845 | 4.8M $ | 0.06 % |
| Alto Neuroscience Inc | 212,677 | 4.8M $ | 0.06 % |
| Bicara Therapeutics Inc | 236,865 | 4.7M $ | 0.06 % |
| GH RESEARCH PLC | 334,162 | 4.7M $ | 0.06 % |
| ArriVent Biopharma Inc | 201,242 | 4.6M $ | 0.06 % |
| CytomX Therapeutics Inc | 987,397 | 4.6M $ | 0.06 % |
| Cullinan Therapeutics Inc | 323,429 | 4.6M $ | 0.06 % |
| Replimune Group Inc | 570,930 | 4.4M $ | 0.05 % |
| Precigen Inc | 1,104,713 | 4.3M $ | 0.05 % |
| Arvinas Inc | 403,100 | 4.3M $ | 0.05 % |
| Savara Inc | 775,563 | 4.2M $ | 0.05 % |
| Ironwood Pharmaceuticals Inc | 1,173,471 | 4.1M $ | 0.05 % |
| Phathom Pharmaceuticals Inc | 356,945 | 4M $ | 0.05 % |
| Zevra Therapeutics Inc | 413,742 | 3.9M $ | 0.05 % |
| Cytek Biosciences Inc | 868,726 | 3.8M $ | 0.05 % |
| MeiraGTx Holdings plc | 430,643 | 3.7M $ | 0.05 % |
| ARS Pharmaceuticals Inc | 463,404 | 3.7M $ | 0.05 % |
| BioAge Labs Inc | 211,362 | 3.7M $ | 0.05 % |
| Sana Biotechnology Inc | 1,235,916 | 3.6M $ | 0.04 % |
| Rigel Pharmaceuticals Inc | 131,031 | 3.5M $ | 0.04 % |
| ZENAS BIOPHARMA INC | 175,941 | 3.4M $ | 0.04 % |
| Compass Pathways plc | 612,150 | 3.4M $ | 0.04 % |
| Fulcrum Therapeutics Inc | 429,371 | 3.3M $ | 0.04 % |
| OPKO Health, Inc. | 2,882,600 | 3.3M $ | 0.04 % |
| Solid Biosciences Inc | 446,552 | 3.2M $ | 0.04 % |
| 4D Molecular Therapeutics Inc | 338,744 | 3.2M $ | 0.04 % |
| Prothena Corp PLC | 323,349 | 3.1M $ | 0.04 % |
| Emergent BioSolutions Inc | 376,503 | 3.1M $ | 0.04 % |
| Myriad Genetics Inc | 662,895 | 3M $ | 0.04 % |
| Absci Corp | 975,088 | 2.9M $ | 0.04 % |
| BridgeBio Oncology Therapeutics Inc | 324,513 | 2.9M $ | 0.04 % |
| Perspective Therapeutics Inc | 693,460 | 2.9M $ | 0.04 % |
| Aclaris Therapeutics Inc | 766,012 | 2.9M $ | 0.04 % |
| Altimmune Inc | 926,610 | 2.9M $ | 0.04 % |
| Vanda Pharmaceuticals Inc | 405,038 | 2.8M $ | 0.03 % |
| Allogene Therapeutics Inc | 1,145,572 | 2.8M $ | 0.03 % |
| REGENXBIO Inc | 331,423 | 2.8M $ | 0.03 % |
| Rocket Pharmaceuticals Inc | 752,567 | 2.7M $ | 0.03 % |
| Pacific Biosciences of California Inc | 2,021,533 | 2.7M $ | 0.03 % |
| Lexeo Therapeutics Inc | 457,447 | 2.6M $ | 0.03 % |
| Alvotech SA | 763,481 | 2.6M $ | 0.03 % |
| Contineum Therapeutics Inc | 200,362 | 2.6M $ | 0.03 % |
| Enanta Pharmaceuticals Inc | 205,184 | 2.6M $ | 0.03 % |
| Lineage Cell Therapeutics Inc | 1,621,430 | 2.6M $ | 0.03 % |
| Standard BioTools Inc | 2,747,556 | 2.5M $ | 0.03 % |
| ADC Therapeutics SA | 673,142 | 2.5M $ | 0.03 % |
| Design Therapeutics Inc | 235,859 | 2.5M $ | 0.03 % |
| Personalis Inc | 393,153 | 2.5M $ | 0.03 % |
| Atea Pharmaceuticals Inc | 460,056 | 2.5M $ | 0.03 % |
| Prime Medicine Inc | 704,092 | 2.5M $ | 0.03 % |